Witnessing the stock’s movement on the chart, on Wednesday, NKGen Biotech Inc (NASDAQ: NKGN) set off with pace as it heaved 4.25% to $0.27, before settling in for the price of $0.26 at the close. Taking a more long-term approach, NKGN posted a 52-week range of $0.20-$4.06.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was -50.00%. This publicly-traded company’s shares outstanding now amounts to $21.89 million, simultaneously with a float of $18.20 million. The organization now has a market capitalization sitting at $9.59 million. At the time of writing, stock’s 50-day Moving Average stood at $0.4699, while the 200-day Moving Average is $1.1513.
NKGen Biotech Inc (NKGN) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. NKGen Biotech Inc’s current insider ownership accounts for 48.77%, in contrast to 13.32% institutional ownership. According to the most recent insider trade that took place on Dec 07 ’23, this organization’s Chief Executive Officer bought 76 shares at the rate of 3.29, making the entire transaction reach 250 in total value, affecting insider ownership by 171,121. Preceding that transaction, on Dec 06 ’23, Company’s Chief Executive Officer bought 75 for 3.32, making the whole transaction’s value amount to 250. This particular insider is now the holder of 171,045 in total.
NKGen Biotech Inc (NASDAQ: NKGN) Trading Performance Indicators
Let’s observe the current performance indicators for NKGen Biotech Inc (NKGN). It’s Quick Ratio in the last reported quarter now stands at 0.02. The Stock has managed to achieve an average true range (ATR) of 0.07.
In the same vein, NKGN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -4.92.
Technical Analysis of NKGen Biotech Inc (NKGN)
Going through the that latest performance of [NKGen Biotech Inc, NKGN]. Its last 5-days volume of 0.49 million was inferior to the volume of 1.8 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 11.62% While, its Average True Range was 0.0663.
Raw Stochastic average of NKGen Biotech Inc (NKGN) in the period of the previous 100 days is set at 5.76%, which indicates a major fall in contrast to 8.43% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 236.66% that was higher than 210.09% volatility it exhibited in the past 100-days period.
